Abstract
Objective: To investigate the clinical and procedural characteristics in patients with a history of renal transplant (RT) and compare the outcomes with patients without RT in 2 national cohorts of patients undergoing percutaneous coronary intervention (PCI). Patients and Methods: Data from the National Inpatient Sample (NIS) and British Cardiovascular Intervention Society (BCIS) were used to compare the clinical and procedural characteristics and outcomes of patients undergoing PCI who had RT with those who did not have RT. The primary outcome of interest was in-hospital mortality. Results: Of the PCI procedures performed in 2004-2014 (NIS) and 2007-2014 (BCIS), 12,529 of 6,601,526 (0.2%) and 1521 of 512,356 (0.3%), respectively, were undertaken in patients with a history of RT. Patients with RT were younger and had a higher prevalence of congestive cardiac failure, hypertension, and diabetes but similar use of drug-eluting stents, intracoronary imaging, and pressure wire studies compared with patients who did not have RT. In the adjusted analysis, patients with RT had increased odds of in-hospital mortality (NIS: odds ratio [OR], 1.90; 95% CI, 1.41-2.57; BCIS: OR, 1.60; 95% CI, 1.05-2.46) compared with patients who did not have RT but no difference in vascular or bleeding events. Meta-analysis of the 2 data sets suggested an increase in in-hospital mortality (OR, 1.79; 95% CI, 1.40-2.29) but no difference in vascular (OR, 1.24; 95% CI, 0.77-2.00) or bleeding (OR, 1.21; 95% CI, 0.86-1.68) events. Conclusion: This large collaborative analysis of 2 national databases revealed that patients with RT undergoing PCI are younger, have more comorbidities, and have increased mortality risk compared with the general population undergoing PCI.
| Original language | English |
|---|---|
| Pages (from-to) | 363-376 |
| Number of pages | 14 |
| Journal | Mayo Clinic Proceedings |
| Volume | 96 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2021 |
Bibliographical note
Publisher Copyright:© 2020 Mayo Foundation for Medical Education and Research
Funding
Potential Competing Interests: Dr Curzen has been a consultant for HeartFlow, Inc, and Haemonetics Corporation; has received grants/has grants pending from Boston Scientific Corporation, HeartFlow, Inc, and Beckmann Coulter, Inc (funds paid to his institution); has received payment for lectures/service on speakers bureaus from Boston Scientific Corporation, HeartFlow, Inc, and Abbott; and has received funds for travel/accommodations/meeting expenses from Edwards Lifesciences Corporation, Biosensors International Group, Ltd, HeartFlow, Inc, and Medtronic. Dr Kwok has been a member of the board for Biosensors International Group (funds paid to his institution for PhD tuition). Dr Banning reports grant support to his institution from Boston Scientific; speaker fees from Boston Scientific, Abbott Vascular, and Medtronic. The National Inpatient Sample (NIS) is one of the largest inpatient databases in the United States. It was established by the Healthcare Cost and Utilization Project and is supported by the Agency for Healthcare Research and Quality (AHRQ). The deidentified survey data come from over 1000 nonfederal hospitals sampled from 45 states and represent over 35 million discharges annually. 18
| Funders |
|---|
| Agency for Healthcare Research and Quality |
| Abbott Laboratories |
| Medtronic |
| Edwards Lifesciences |
| Boston Scientific Neuromodulation Corporation |
| Haemonetics Corporation |
| Biosensors International Group |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Outcomes Following Percutaneous Coronary Intervention in Renal Transplant Recipients: A Binational Collaborative Analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver